^
    almost3years
    A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=50, Not yet recruiting, Qilu Pharmaceutical Co., Ltd.
    New P1 trial • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    QLS12004